FacebookTwitterGoogle+RedditEmail

Patient Front Groups Loot Medicare Dollars for Big Pharma

by MARTHA ROSENBERG

The Obama administration is finally addressing the expensive, dangerous and usually unnecessary psychiatric drugs that are footed by taxpayers in federal entitlement programs. It has proposed that insurers may limit Medicare coverage of certain classes of drugs that include Wellbutrin, Paxil and Prozac for depression and Abilify and Seroquel for schizophrenia.

How expensive are these drugs? 100 middle dose pills of the widely marketed Abilify cost as much as $1,644. 100 pills of Geodon are $958, Invega, $1,789, Risperdal, $953, Seroquel, $2,000 and Zyprexa, $1,680, if the brand name drugs are used, which drug company  lobbyists hope. Thanks to their lobbying, insurers have to pay “all or substantially all” of such depression and schizophrenia drug costs because the drugs enjoy “protected status” in the Medicare program. Such protected pills account for as much as 33 percent of total outpatient drug spending under Part D of Medicare, says the New York Times.

Not surprisingly, Big Pharma and its patient front groups are livid that the heisting of US taxpayers dollars could be curtailed. Abilify alone has earned over $4 billion a year! “The proposal undermines a key protection for some of the sickest, most vulnerable Medicare beneficiaries,” said Andrew Sperling, a lobbyist at the National Alliance on Mental Illness (NAMI) which is fighting the Obama proposal.

As much as 75 percent of NAMI’s donations come from drug companies says the New York Times and it has been investigated by Congress. Portraying itself as “patients,” NAMI also successfully fights states’ efforts to limit use of the most pricey Medicaid psychiatric drugs, in parallel lobbying. “Some of these medicines routinely top the list of the most expensive drugs that states buy for their poorest patients,” says the Times. NAMI is “hugely influential in many state capitols,” it adds.

The heart of Big Pharma and NAMI lobbying is making sure expensive drugs are on Medicare and Medicaid formularies and that doctors prescribe them first–before and instead of lower priced drugs. The expensive-drugs-first marketing is couched as “patient choice” or another “treatment option” by Pharma lobbyists as if there’s no difference between a $45 prescription and $450 prescription. Antipsychotic drugs work in different ways in the body explains Sperling and “You get much better outcomes when a doctor can work with patients to figure out which medications will work best for them.” Ka-ching.

The problem is newer, more expensive drugs are not necessarily better than older, less expensive drugs and they are often more dangerous. One chilling example is an estimated 15,000 elderly people die in nursing homes a year from inappropriately given antipsychotic medications, according to FDA drug reviewer David Graham, MD.  Pharma is aware of the profiteering and “laughing all the way to the bank,” Graham speculated.

Antipsychotics like Seroquel carry warnings that they cause death in elderly people who have dementia but are nevertheless in wide use in many geriatric, federally-supported facilities. So much for NAMI’s concern for “the sickest, most vulnerable Medicare beneficiaries.”

NAMI is not the only group to play on the public’s heart strings to keep drug revenues flowing. Pharma’s aggressive opioid lobby says patients with legitimate pain will suffer if drugs like Oxycontin, killing 17,000 Americans a year, are regulated. Similarly, if Abilify and Seroquel are regulated within Medicare, someone will suffer–Big Pharma.

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

 

 

 

 

 

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

CounterPunch Magazine

minimag-edit

bernie-the-sandernistas-cover-344x550

zen economics

Weekend Edition
July 28, 2017
Friday - Sunday
Diana Johnstone
Collateral Damage: U.S. Sanctions Aimed at Russia Strike Western European Allies
Jim Kavanagh
Donald the Destroyer: Assessing the Trump Effect
Carl Boggs
The Other Side of War: Fury and Repression in St. Louis
Eva Golinger
There is Still Time to Prevent Civil War in Venezuela
Anthony DiMaggio
“A Better Deal”? Dissecting the Democrats’ “Populist” Turn in Rhetoric and Reality
Conn Hallinan
Middle East Chaos
Mumia Abu-Jamal
James Baldwin: Word Warrior
Joshua Frank
The Fire Beneath: Los Angeles is Sitting on a Ticking Time Bomb
Myles Hoenig
It Wasn’t Russia, It was the Green Party!
Andrew Levine
Enter Scaramouche, Stage Right
Brian Cloughley
Time to Get Out of Afghanistan
Gary Leupp
The Trump Revolution Devouring Its Own Children
John Wright
Trump’s Hezbollah Gaff Was No Gaff
Alan Jones
“Finland Station” and the Struggle for Socialism Today
Robert Hunziker
Plastic Chokes the Seas
Eric Draitser
Enough Nonsense! The Left Does Not Collaborate with Fascists
Vijay Prashad
The FBI vs. Comrade Charlie Chaplin
Jane LaTour
Danger! Men Working
Yoav Litvin
The Unbearable Lightness of Counterrevolution
Charles Derber
Universalizing Resistance: How to Trump Trump
Gregory Barrett
Two Johnstones and a Leftish Dilemma: Nationalism vs. Neoliberalism
Joseph Natoli
Choosing the ‘Arteries that Make Money’
CJ Hopkins
Intersectionalist Internet Blues
Pepe Escobar
China and India Torn Between Silk Roads and Cocked Guns
Ralph Nader
Can the World Defend Itself From Omnicide?
Howard Lisnoff
Agape While Waltzing at the Precipice
Musa Al-Gharbi
Want to Shake Up Status Quo? Account for the Default Effect
Angela Kim
North Korean Policy Must Focus on Engagement Not Coercion
Hiroyuki Hamada
Delivering Art in the Empire
David Macaray
Talking Union
Binoy Kampmark
Refugee Conundrums: Resettlement, the UN and the US-Australia Deal
Robert Koehler
Opening Gitmo to the World
David Jaffee
No Safe Space for Student X
Thomas Knapp
The State is at War — With the Future
David Swanson
What’s Missing from Dunkirk Film
Winslow Myers
There Is Still Time, Brother
Robert J. Burrowes
Biological Annihilation on Earth Accelerating
Frederick B. Hudson – Dr. Junis Warren
Robot Scientists Carry Heavy Human Hearts 
Randy Shields
Not My Brother’s Reefer
Sam Lichtman
Where are the Millennials?
Louis Proyect
Death Race: the Cruelties of the Iditarod
Charles R. Larson
Review: Norman Lock’s A Fugitive in Walden Woods
July 27, 2017
Edward Curtin
The Deep State, Now and Then
Melvin Goodman
The Myth of American Exceptionalism
Nozomi Hayase
From Watergate to Russiagate: the Hidden Scandal of American Power
FacebookTwitterGoogle+RedditEmail